Global expression-based classification of lymph node metastasis and extracapsular spread of oral tongue squamous cell carcinoma

Neoplasia

Volumn 8, Issue 11, 2006, Pages 925-932

  Zhou, Xiaofeng ^a,b,c   Temam, Stephane ^d,e   Oh, Myungshin ^a,f   Pungpravat, Nisa ^a   Huang, Bau Lin ^a   Mao, Li ^d   Wong, David T ^a,b,g  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^e INSTITUT GUSTAVE ROUSSY   (France)

^f UNIVERSITY OF CALIFORNIA   (United States)

^g UCLA SCHOOL OF DENTISTRY   (United States)

Author keywords

Extracapsular spread; Leave one out cross validation; Lymph node metastasis; Microarray; Squamous cell carcinoma

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; BONE MORPHOGENETIC PROTEIN 2; CELL CYCLE PROTEIN; CORTACTIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EUKARYOTIC TRANSLATION ELONGATION FACTOR 1 ALPHA1; GELATINASE B; INITIATION FACTOR; PROTEIN G 2 AND S PHASE EXPRESSED 1; PROTEIN MITOCHONDRIAL TUMOR SUPPRESSOR 1; RNA; TUMOR MARKER; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUAMOUS CELL CARCINOMA; TONGUE CARCINOMA;

EID: 33750696635     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.06430     Document Type: Article

References (40)

1. Pantel K and Brakenhoff RH (2004). Dissecting the metastatic cascade. Nat Rev Cancer 4 (6), 448-456.
2. 0 neck. Br J Oral Maxillofac Surg 37 (3), 205-209.
3. Jones AS, Phillips DE, Helliwell TR, and Roland NJ (1993). Occult node metastases in head and neck squamous carcinoma. Eur Arch Otorhinolaryngol 250 (8), 446-449.
4. 0 neck. Laryngoscope 107 (10), 1294-1315.
5. Robbins KT, Clayman G, Levine PA, Medina J, Sessions R, Shaha A, Som P, and Wolf GT (2002). Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology - Head and Neck Surgery. Arch Otolaryngol Head Neck Surg 128 (7), 751-758.
6. Short SO, Kaplan JN, Laramore GE, and Cummings CW (1984). Shoulder pain and function after neck dissection with or without preservation of the spinal accessory nerve. Am J Surg 148 (4), 478-482.
7. van Wilgen CP, Dijkstra PU, van der Laan BF, Plukker JT, and Roodenburg JL (2004). Shoulder and neck morbidity in quality of life after surgery for head and neck cancer. Head Neck 26 (10), 839-844.
8. van Wilgen CP, Dijkstra PU, van der Laan BF, Plukker JT, and Roodenburg JL (2004). Morbidity of the neck after head and neck cancer therapy. Head Neck 26 (9), 785-791.
9. van Wilgen CP, Dijkstra PU, Nauta JM, Vermey A, and Roodenburg JL (2003). Shoulder pain and disability in daily life, following supraomohyoid neck dissection: a pilot study. J Craniomaxillofac Surg 31 (3), 183-186.
10. Nakamura K, Ozaki N, Yamada T, Hata T, Sugimoto S, Hikino H, Kanazawa A, Tokuka A, and Nagaoka S (2005). Evaluation of prognostic significance in extracapsular spread of lymph node metastasis in patients with gastric cancer. Surgery 137 (5), 511-517.
11. Yamashita H, Noguchi S, Murakami N, Kawamoto H, and Watanabe S (1997). Extracapsular invasion of lymph node metastasis is an indicator of distant metastasis and poor prognosis in patients with thyroid papillary carcinoma. Cancer 80 (12), 2268-2272.
12. van der Velden J, van Lindert AC, Lammes FB, ten Kate FJ, Sie-Go DM, Oosting H, and Heintz AP (1995). Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival. Cancer 75 (12), 2885-2890.
13. Mambo NC and Gallager HS (1977). Carcinoma of the breast: the prognostic significance of extranodal extension of axillary disease. Cancer 39 (5), 2280-2285.
14. Greenberg JS, Fowler R, Gomez J, Mo V, Roberts D, El Naggar AK, and Myers JN (2003). Extent of extracapsular spread: a critical prognosticator in oral tongue cancer. Cancer 97 (6), 1464-1470.
15. Myers JN, Greenberg JS, Mo V, and Roberts D (2001). Extracapsular spread. A significant predictor of treatment failure in patients with squamous cell carcinoma of the tongue. Cancer 92 (12), 3030-3036.
16. Ramaswamy S, Ross KN, Lander ES, and Golub TR (2003). A molecular signature of metastasis in primary solid tumors. Nat Genet 33 (1), 49-54.
17. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M, Peterse HL, van der Kooy K, Marton MJ, Witteveen AT, et al. (2002). Gene expression profiling predicts clinical outcome of breast cancer. Nature 415 (6871), 530-536.
18. Schmalbach CE, Chepeha DB, Giordano TJ, Rubin MA, Teknos TN, Bradford CR, Wolf GT, Kuick R, Misek DE, Trask DK, et al. (2004). Molecular profiling and the identification of genes associated with metastatic oral cavity/pharynx squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 130 (3), 295-302.
19. O'Donnell RK, Kupferman M, Wei SJ, Singhal S, Weber R, O'Malley B, Cheng Y, Putt M, Feldman M, Ziober B, et al. (2005). Gene expression signature predicts lymphatic metastasis in squamous cell carcinoma of the oral cavity. Oncogene 24 (7), 1244-1251.
20. Roepman P, Wessels LF, Kettelarij N, Kemmeren P, Miles AJ, Lijnzaad P, Tilanus MG, Koole R, Hordijk GJ, van der Vliet PC, et al. (2005). An expression profile for diagnosis of lymph node metastases from primary head and neck squamous cell carcinomas. Nat Genet 37 (2), 182-186.
21. Ohyama H, Zhang X, Kohno Y, Alevizos I, Posner M, Wong DT, and Todd R (2000). Laser capture microdissection-generated target sample for high-density oligonucleotide array hybridization. Biotechniques 29 (3), 530-536.
22. Affymetrix (2002). Statistical Algorithms Description Document. Affymetrix, Santa Clara, CA, USA.
23. Li C and Wong WH (2001). Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98 (1), 31-36.
24. Irizarry RA, Bolstad BM, Collin F, Cope LM, Hobbs B, and Speed TP (2003). Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res 31 (4), e15.
25. Li Y, St John MA, Zhou X, Kim Y, Sinha U, Jordan RC, Eisele D, Abemayor E, Elashoff D, Park NH, et al. (2004). Salivary transcriptome diagnostics for oral cancer detection. Clin Cancer Res 10 (24), 8442-8450.
26. Livak KJ and Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(Delta Delta C(T)) method. Methods 25 (4), 402-408.
27. Renger R and Meadows LM (1994). Use of stepwise regression in medical education research. Acad Med 69 (9), 738.
28. Li Y, Elashoff D, Oh M, Sinha U, St John MA, Zhou X, Abemayor E, and Wong DT (2006). Serum circulating human mRNA profiling and its utility for oral cancer detection. J Clin Oncol 24 (11), 1754-1760.
29. Dobrossy L (2005). Epidemiology of head and neck cancer: magnitude of the problem. Cancer Metastasis Rev 24 (1), 9-17.
30. Timar J, Csuka O, Remenar E, Repassy G, and Kasler M (2005). Progression of head and neck squamous cell cancer. Cancer Metastasis Rev 24 (1), 107-127.
31. Franceschi D, Gupta R, Spiro RH, and Shah JP (1993). Improved survival in the treatment of squamous carcinoma of the oral tongue. Am J Surg 166 (4), 360-365.
32. Osman M, Tortorella M, Londei M, and Quaratino S (2002). Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases define the migratory characteristics of human monocyte-derived dendritic cells. Immunology 105 (1), 73-82.
33. Turner HE, Nagy Z, Esiri MM, Harris AL, and Wass JA (2000). Role of matrix metalloproteinase 9 in pituitary tumor behavior. J Clin Endocrinol Metab 85 (8), 2931-2935.
34. Schuuring E, Verhoeven E, Mooi WJ, and Michalides RJ (1992). Identification and cloning of two overexpressed genes, U21B31/PRAD1 and EMS1, within the amplified chromosome 11q13 region in human carcinomas. Oncogene 7 (2), 355-361.
35. Schuuring E, van Damme H, Schuuring-Scholtes E, Verhoeven E, Michalides R, Geelen E, de Boer C, Brok H, van Buuren V, and Kluin P (1998). Characterization of the EMS1 gene and its product, human Cortactin. Cell Adhes Commun 6 (2-3), 185-209.
36. Schuuring E (1995). The involvement of the chromosome 11q13 region in human malignancies: cyclin D1 and EMS1 are two new candidate oncogenes - a review. Gene 159 (1), 83-96.
37. Grandis JR and Tweardy DJ (1993). Elevated levels of transforming growth factor a and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 53, 3579-3584.
38. Dassonville O, Formento JL, Francoual M, Santini J, Schneider M, Demard F, and Milano G (1993). Expression of epidermal growth factor receptor and survival in upper aerodigestive tract cancer. J Clin Oncol 11, 1873-1878.
39. Monte M, Collavin L, Lazarevic D, Utrera R, Dragani TA, and Schneider C (2000). Cloning, chromosome mapping and functional characterization of a human homologue of murine gtse-1 (B99) gene. Gene 254 (1-2), 229-236.
40. Monte M, Benetti R, Collavin L, Marchionni L, Del Sal G, and Schneider C (2004). hGTSE-1 expression stimulates cytoplasmic localization of p53. J Biol Chem 279 (12), 11744-11752.